TaiwanJ Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	67.82	47.61	58.83	60.69	82.88
Short-Term Investments	-	40	-	-	-
Cash & Short-Term Investments	67.82	87.61	58.83	60.69	82.88
Cash Growth	-22.58%	48.92%	-3.06%	-26.77%	-11.31%
Accounts Receivable	-	-	-	4.61	-
Other Receivables	0.24	4.98	4.85	5.68	5.26
Receivables	0.24	4.98	4.85	10.29	5.26
Prepaid Expenses	-	0.27	0.18	0.17	0.25
Other Current Assets	5.36	0.33	0.23	0.02	0
Total Current Assets	73.42	93.18	64.09	71.17	88.39
Property, Plant & Equipment	2.25	1.51	3.04	3.03	0.32
Other Intangible Assets	-	-	0.36	0.94	76.8
Other Long-Term Assets	1.58	6.08	6.08	4.65	4.83
Total Assets	77.25	100.77	73.56	79.79	170.33
Accrued Expenses	-	4.15	4.5	4.45	5.16
Current Portion of Leases	0.78	0.47	0.7	0.69	0.33
Other Current Liabilities	4.54	1.09	0.95	1.88	1.36
Total Current Liabilities	5.32	5.71	6.15	7.02	6.85
Long-Term Leases	1.01	-	0.47	1.17	-
Total Liabilities	6.33	5.71	6.62	8.19	6.85
Common Stock	801.22	801.22	751.22	751.22	751.22
Additional Paid-In Capital	2.64	2.43	1.97	0.59	-
Retained Earnings	-732.94	-708.59	-686.25	-680.2	-587.74
Shareholders' Equity	70.92	95.05	66.94	71.6	163.48
Total Liabilities & Equity	77.25	100.77	73.56	79.79	170.33
Total Debt	1.79	0.47	1.17	1.86	0.33
Net Cash (Debt)	66.04	87.14	57.66	58.83	82.55
Net Cash Growth	-24.21%	51.12%	-1.99%	-28.73%	-10.81%
Net Cash Per Share	0.81	1.14	0.77	0.78	1.10
Filing Date Shares Outstanding	82.16	80.12	75.12	75.12	75.12
Total Common Shares Outstanding	82.16	80.12	75.12	75.12	75.12
Working Capital	68.11	87.47	57.94	64.16	81.54
Book Value Per Share	0.86	1.19	0.89	0.95	2.18
Tangible Book Value	70.92	95.05	66.58	70.67	86.69
Tangible Book Value Per Share	0.86	1.19	0.89	0.94	1.15
Machinery	-	3.86	3.86	2.83	2.83
Leasehold Improvements	-	1.64	1.64	1.23	2.56

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.